Company Description: Tioga Pharmaceuticals is planning to conduct a phase 2 trial of its selective kappa-opioid receptor agonist, asimadoline, for the treatment of associated with atopic pruritus.
Technologies: tiogapharma.com is using 2 Technologies.
Social Media: tiogapharma.com has 1 social media shares and likes.
We have 1 emails for tiogapharma.com.
Verified Contacts from
Similar Startups Companies
Use our PerfectLink™ Contact Finder to verify contacts.
Additional Info and Employees
Tioga Pharmaceuticals develops therapies for the treatment of gastrointestinal diseases.
Sign up to get full access to all the tiogapharma.com emails we have.
Find emails for tiogapharma.com executives, including the Chief Executive Officer, Chief Financial Officer, and Chief Marketing Officer.